Response to Letter: Emerging Biomarkers in the No-Reflow Phenomenon: Unveiling the Inflammatory Connection

Abstract

Get full access to this article

View all access options for this article.

References

Özlek

Barutçu

Tanik

VO.

Letter: emerging biomarkers in the no-reflow phenomenon: unveiling the inflammatory connection. Angiology. 2025;76(10):1031-1032.

Aydemir

Aydın

Altınkaya

Aksakal

Özmen

Evaluation of hematological and biochemical parameters that predict the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention. Angiology. 2025;76(10):999-1009.

Shen

Qiu

Yang

, et al. Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study. BMC Cancer. 2024;24(1):1393.

Feng

Wang

Yang

Lou

Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma. BMC Cancer. 2022;22(1):284.

Tunca

Büyükbaş

Taş

Tanık

Barutçu

Özlek

The Osaka Prognostic Score predicts all-cause in-hospital mortality in patients with non-ST-elevation myocardial infarction undergoing early percutaneous coronary intervention. Angiology. Published online September 23, 2025. doi:10.1177/00033197251370103

Taş

Tunca

Tanık

Özlek

The Scottish inflammatory prognostic score: a novel biomarker for predicting in-hospital mortality in acute heart failure with reduced ejection fraction. Heart Lung. 2025;74:291-299.